2 Notes on the scope of the guidance
NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover.
This guideline addresses the diagnosis, treatment and management of CFS/ME in adults and in children aged 5 years and older, in primary and secondary care and in specialist centres and teams. The guideline is also relevant to the work of occupational health services, social services, educational services and the voluntary sector, although it does not make recommendations for them directly.
The guideline does not cover the management of comorbidities, highly specialised procedures, service provision or models of care.
How this guideline was developed
NICE commissioned the National Collaborating Centre for Primary Care to develop this guideline. The Centre established a Guideline Development Group (see appendix A), which reviewed the evidence and developed the recommendations. An independent Guideline Review Panel oversaw the development of the guideline (see appendix B).
There is more information about how NICE clinical guidelines are developed on the NICE website. A booklet, 'How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS' is available.